The HJ MILE HIV Prevention Intervention for Post-incarcerated Men

Sponsor
University of Southern California (Other)
Overall Status
Completed
CT.gov ID
NCT01427543
Collaborator
Charles Drew University of Medicine and Science (Other), Centers for Disease Control and Prevention (U.S. Fed)
212
1
2
21
10.1

Study Details

Study Description

Brief Summary

The goal of this study is to determine whether a culturally congruent, group intervention can reduce HIV risk behaviors among recently incarcerated, bisexual, African American men.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: MILE intervention
Phase 3

Detailed Description

The goal of this study is to evaluate the efficacy of the Men in Life Environments (MILE) intervention, adapted from the Men of African American Legacy Empowering Self (MAALES) Project, an innovative and culturally congruent intervention designed to reduce HIV risk-related behaviors and improve psychosocial outcomes in recently incarcerated African American men who have sex with men and women (MSMW). The MILE intervention is guided by the Theory of Reasoned Action and Planned Behavior, the Critical Thinking and Cultural Affirmation (CTCA) Model, and the Empowerment Theory. The small group MILE intervention involves six two-hour group sessions held over three weeks and is lead by two African-American co-facilitators. The investigators will test the intervention with a total of 260 African American MSMW, evenly randomized to intervention and control conditions. For this study, participants will be interviewed at baseline, shortly after completion of the intervention (~ 4 weeks after baseline), and again 3 months following the second interview. This project will be among the first to develop and test an HIV risk-reduction intervention designed specifically for African American post-incarcerated MSMW. Study aims are as follows:

Aim 1: To evaluate the impact of the MILE intervention on rates of condom use, having sex while under the influence of drugs and alcohol, and number of sex partners among recently incarcerated bisexual African American MSMW.

Hypothesis: Compared to the control condition, the MILE intervention condition will be more effective in decreasing episodes of unprotected anal and vaginal intercourse, incidents of sex under the influence of drugs and alcohol and numbers of intercourse partners at the 3-month follow-up assessment.

Aim 2: To evaluate the impact of the MILE intervention on uptake of testing for sexually transmitted infections (STI) among recently incarcerated African American MSMW.

Hypothesis: Compared to the control condition, the MILE intervention participants will be more likely to accept STI testing after the post-intervention assessment.

Aim 3: To describe social support and social networks of recently incarcerated African American MSMW and to examine whether these factors are associated with HIV risk in this population.

The MILE intervention will be implemented by The Center for Health Justice (CHJ) - a community-based HIV prevention and care advocacy organization that has been working with incarcerated and post-incarcerated populations since 1997. The adaptation and implementation of this intervention by CHJ should increase the dissemination and applicability of the intervention to other locales should it prove to be effective.

Study Design

Study Type:
Interventional
Actual Enrollment :
212 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Prevention
Official Title:
The HJ MILE HIV Prevention Intervention for Post-incarcerated Bisexual African American Men
Study Start Date :
Jul 1, 2011
Actual Primary Completion Date :
Apr 1, 2013
Actual Study Completion Date :
Apr 1, 2013

Arms and Interventions

Arm Intervention/Treatment
Experimental: MILE group sessions

Participants will attend 6 - 2 hour long, interactive, culturally congruent, group sessions that address knowledge, beliefs, attitudes, and skills related to reducing HIV risk behaviors.

Behavioral: MILE intervention
Participants will be asked to attend 6 - 2 hour group sessions over the course of 3 weeks. The intervention aims to reduce HIV risk taking related to sex risk and alcohol and drug use.

No Intervention: Control

These subjects will be provided with access to post-incarcerations services that will be provided by the Center for Health Justice.

Outcome Measures

Primary Outcome Measures

  1. Condom use [Last 3 months]

    This measure captures the percentage of times that participants self-report using a condom during vaginal and anal sex.

  2. Sex under the influence of alcohol and drugs [Last 3 months]

    Self-reported vaginal or anal sex while under the influence of alcohol or drugs.

  3. Number of sex partners [Last 3 month]

    Participant's self-report of number of sex partners in the last 3 months.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
Male
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • self-identified as African American or Black

  • male

  • 18 years of age or greater

  • Los Angeles County resident

  • Been incarcerated in the last 12 months

  • oral or anal sex with a man in the last 12 months

  • any unprotected anal or vaginal sex in the last 3 months

  • two or more sex partners in the last 3 months

Exclusion Criteria:
  • Female or transgendered

  • not self-identified as African American or Black

  • any self-reported illicit drug injection in the last 12 months

Contacts and Locations

Locations

Site City State Country Postal Code
1 Center for Health Justice Los Angeles California United States 90012

Sponsors and Collaborators

  • University of Southern California
  • Charles Drew University of Medicine and Science
  • Centers for Disease Control and Prevention

Investigators

  • Principal Investigator: Ricky Bluthenthal, Ph.D., University of Southern California

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Ricky Bluthenthal, Professor, University of Southern California
ClinicalTrials.gov Identifier:
NCT01427543
Other Study ID Numbers:
  • HS-10-00590
  • 5UR6PS001098
First Posted:
Sep 1, 2011
Last Update Posted:
Oct 12, 2018
Last Verified:
Oct 1, 2018
Keywords provided by Ricky Bluthenthal, Professor, University of Southern California

Study Results

No Results Posted as of Oct 12, 2018